Carl Hull, Thomas MacMahon 

Former Gen-Probe Chairman and CEO Carl Hull and former Laboratory Corporation of American Chairman and CEO Thomas MacMahon have joined the board of Ortho Clinical Laboratories as independent members. 

Hull has more than 30 years of experience in the life sciences and diagnostics markets, and in addition to his stint at Gen-Probe, he held executive positions at Applied Biosystems, Applied Imaging, Ventana Medical Systems, and Abbott Diagnostics. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.